*EMBARGOED All research presented at the 2024 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 27, 2024, at 12:00 pm ET.
P2357 – Hormone Replacement Therapy Is Associated With Increased Risk of Developing Irritable Bowel Syndrome in Post-Menopausal Women
Monday, October 28, 2024 | 10:30 AM – 4:00 PM ET | Exhibit Hall E
Author Insight from Jacqueline Khalil, MS, DO
What’s new here and important for clinicians?
Our study reveals a compelling association between HRT and an increased risk of developing IBS, which persists overtime. Additionally, HRT is correlated with elevated gastrointestinal symptoms, medications used commonly in IBS patients and increased diagnostic testing. Clinicians should be cognizant about the gastrointestinal side effects when prescribing HRT.
What do patients need to know?
Post-menopausal women prescribed HRT should be aware of the potential effects of HRT, particularly regarding IBS.
Author Contact
Jacqueline Khalil, MS, DO
Case Western Reserve University/Metro Health
Beachwood, OH
Jkhalil [at] metrohealth.org
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.